Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils Vrije Universiteit Brussel
active site of human lysozyme has been generated, and its effects on the properties of the I56T and D67H
amyloidogenic variants of human lysozyme, which are associated with a form of systemic amyloidosis,
have been investigated by a wide range of biophysical techniques. Pulse-labeling hydrogen-deuterium
exchange experiments monitored by ...